(Q33195555)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14650924%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

review article

1 reference

title

Functional studies of cholinergic activity in normal and Alzheimer disease states by imaging technique (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14650924%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14650924%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1

Agneta Nordberg

1 reference

23 July 2017

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14650924%20AND%20SRC:MED&resulttype=core&format=json

Progress in Brain Research

21 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14650924%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

145

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14650924%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

301-310

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14650924%20AND%20SRC:MED&resulttype=core&format=json

Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Brain activation in young and older adults during implicit and explicit retrieval

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Imaging cognition II: An empirical review of 275 PET and fMRI studies

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

No difference in cerebral glucose metabolism in patients with Alzheimer disease and differing apolipoprotein E genotypes.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

A fronto-parietal network for rapid visual information processing: a PET study of sustained attention and working memory

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Nicotinic receptor abnormalities in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Alzheimer neuropathologic alterations in aged cognitively normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Mapping muscarinic receptors in human and baboon brain using [N-11C-methyl]-benztropine.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Practice parameter: Management of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Mild cognitive impairment in the elderly: predictors of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Cholinergic stimulation alters performance and task-specific regional cerebral blood flow during working memory

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Cholinergic enhancement and increased selectivity of perceptual processing during working memory.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Do cholinesterase inhibitors have disease-modifying effects in Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Absence of cognitive impairment or decline in preclinical Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Early diagnosis of Alzheimer disease with positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Cortical responses to sustained and divided attention in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Regional distribution of subtypes of nicotinic receptors in human brain and effect of aging studied by (+/-)-[3H]epibatidine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: observations based on the distribution of acetylcholinesterase and choline acetyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Clinical studies in Alzheimer patients with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Neuroprotection in Alzheimer's disease - new strategies for treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

The cholinergic hypothesis--ten years on.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Attention and executive deficits in Alzheimer's disease. A critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Mild cognitive impairment: clinical characterization and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Mild cognitive impairment and the cholinergic hypothesis: a very different take on recent data

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Effect of donepezil on brain acetylcholinesterase activity in patients with AD measured by PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Early detection of Alzheimer's disease by combining apolipoprotein E and neuroimaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Radiolabeled cholinesterase substrates: in vitro methods for determining structure-activity relationships and identification of a positron emission tomography radiopharmaceutical for in vivo measurement of butyrylcholinesterase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Functional MRI detection of pharmacologically induced memory impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Cerebral glucose metabolism, cerebrospinal fluid-beta-amyloid1-42 (CSF-Abeta42), tau and apolipoprotein E genotype in long-term rivastigmine and tacrine treated Alzheimer disease (AD) patients

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Upregulation of neuronal nicotinic receptor subunits alpha4, beta2, and alpha7 in transgenic mice overexpressing human acetylcholinesterase.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Cerebral blood flow and cognitive responses to rivastigmine treatment in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Lack of association of apolipoprotein E epsilon4 allele dose with cerebral glucose metabolism in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021

Kinetic analysis of regional (S)(-)11C-nicotine binding in normal and Alzheimer brains--in vivo assessment using positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2945021-8

7 January 2021